Myelin-Binding Fluorophore
Showing 26 - 50 of 1,387
Schizophrenia Trial in Milan (Lurasidone)
Recruiting
- Schizophrenia
-
Milan, Lombardy, ItalyU.O.C. Psichiatria - Fondazione IRCCS Ca' Granda Ospedale Maggio
Apr 22, 2022
Advanced Gynecologic Tumors, TIL Engineered With Membrane-Binding Cytokine, Treatment Side Effects Trial in Shanghai (Membrane
Recruiting
- Advanced Gynecologic Tumors
- +3 more
- Membrane Bound Cytokine Modified TIL
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Jul 25, 2022
Water and Electrolytes Content in HYpertension (WHYSKI) in SKIn
Recruiting
- Hyperaldosteronism
- +7 more
- Skin Biopsy
- Video-laparoscopic adrenalectomy
-
Padova, ItalyAzienda Ospedale Università di Padova
Oct 23, 2023
Adaptive Mechanisms In GRown up ObeSity Study (AMIGROS)
Recruiting
- Obesity
- Type 2 Diabetes
- Subcutaneous microdialysis
-
Gothenburg, Region Vastra Gotaland, SwedenGothia Forum CTC
Sep 26, 2023
MDD Trial in London (MIJ821)
Not yet recruiting
- Major Depressive Disorder
-
London, United KingdomParexel Early Phase Clinical Unit (LONDON)
Dec 18, 2022
Acute Demyelinating Syndrome Trial in France (Immediate Azathioprine (1st attack), Immediate Rituximab (1st attack), Standard of
Not yet recruiting
- Acute Demyelinating Syndrome
- Immediate Azathioprine (1st attack)
- +2 more
-
Besançon, France
- +8 more
Sep 14, 2022
Leukodystrophy, White Matter Disease, Leukoencephalopathies Trial in United States
Recruiting
- Leukodystrophy
- +21 more
-
Palo Alto, California
- +8 more
Dec 21, 2021
Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- IMCY-0141
- +2 more
-
Chisinau, Moldova, Republic ofRepublican Clinical Hospital, ARENSIA Exploratory Medicine
Jun 8, 2022
Central and Peripheral Nervous System Changes as Markers of
Completed
- Multiple Sclerosis
- +7 more
-
Sønderborg, Jylland, DenmarkDepartment of Neurology (Skleroseklinikken), Sygehus Sønderjylla
Oct 13, 2021
Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding
Terminated
- Inflammatory Bowel Disease
- Non interventional study
- (no location specified)
Mar 16, 2022
Heparin Binding Protein asPrognostic Biomarker of Sepsis
Completed
- Sepsis
- HBP
-
Minya, EgyptOmar Hamdy
Nov 5, 2022
Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia
Completed
- Acute Lymphoblastic Leukemia
- Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
- Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 26, 2022
to Evaluate the Effect of Oral Administration of Bovine Lactoferrin on the Neurobehavioral Performance of Preterm Neonates Trial
Completed
- to Evaluate the Effect of Oral Administration of Bovine Lactoferrin on the Neurobehavioral Performance of Preterm Neonates
- bovine lactoferrin
-
Cairo, Al Qahirah, EgyptAin Shams University Hospitals
Aug 22, 2023
Alcohol Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)
Completed
- Alcohol Use Disorder
- [C-11]
- NOP-1A
-
Pittsburgh, PennsylvaniaUniversity of PIttsburgh PET Facility
Jul 8, 2022
Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)
Not yet recruiting
- Monoclonal Gammopathy of Uncertain Significance
- Zanubrutinib Oral Product
-
Utrecht, NetherlandsUniversity Medical Center Utrecht
Jul 6, 2023
Spinal Cord Injury Trial in Bronx (Natesto testosterone intranasal gel, Ayr Saline Nasal Gel)
Not yet recruiting
- Spinal Cord Injury
- Natesto testosterone intranasal gel
- Ayr Saline Nasal Gel
-
Bronx, New YorkJames J. Peters VA Medical Center, Bronx, NY
Nov 8, 2023
Sleep Disorder, Healthy Trial in Baltimore (Sleep Fragmentation, Within-Subject test of blinded study medication (stimulant,
Recruiting
- Sleep Disorder
- Healthy
- Sleep Fragmentation
- +3 more
-
Baltimore, MarylandJohns Hopkins School of Medicine
Nov 14, 2022
Immunogenicity, Safety, Efficacy Trial in Savannakhét (SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2.,
Active, not recruiting
- Immunogenicity
- +2 more
- SW-BIC-213;SARS-Cov-2.
- +2 more
-
Savannakhét, Sava, Lao People's Democratic RepublicSavannakhét Provincial hospital
Jan 8, 2023
Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion Trial in San Francisco (Clemastine
Not yet recruiting
- Demyelinating Diseases
- +4 more
- Clemastine Fumarate
- Placebo
-
San Francisco, CaliforniaSandler Neurosciences Building, Neurological Clinical Research U
Oct 3, 2023
Placenta Accreta Spectrum Pregnancies
Completed
- Placenta Accreta, Third Trimester
- Galectin 3
-
Konya, TurkeyNecmettin Erbakan University Meram Medicine Faculty
Jul 6, 2023